Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 106846
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.106846
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.106846
Long-term survival of a patient with colorectal cancer with peritoneal carcinomatosis and low completeness of cytoreduction score: A case report
Jung Wook Suh, Jae Won Jo, Dong-Guk Park, Department of Surgery, Dankook University Hospital, Cheonan 31116, Chungcheongnam-do, South Korea
Author contributions: Suh JW drafted the manuscript; Jo JW curated the data; Park D reviewed and edited the manuscript.
Supported by a Research Fund from Dankook University in 2024, No. R202400759.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong-Guk Park, PhD, CEO, Full Professor, Department of Surgery, Dankook University Hospital, 201 Manghyang-ro, Cheonan 31116, Chungcheongnam-do, South Korea. dkp21876@gmail.com
Received: March 9, 2025
Revised: March 27, 2025
Accepted: April 27, 2025
Published online: June 15, 2025
Processing time: 97 Days and 4.5 Hours
Revised: March 27, 2025
Accepted: April 27, 2025
Published online: June 15, 2025
Processing time: 97 Days and 4.5 Hours
Core Tip
Core Tip: Long-term survival of patients with a completeness of cytoreduction score of 3 is rarely observed; nonetheless, a favorable outcome was attained in this case by using tailored, multimodal treatment. Despite a substantial residual tumor burden, the 61-year-old female patient survived at least 6 years, suggesting the benefit of aggressive, multimodal treatment even in advanced disease. Despite the challenges in preoperatively identifying patients suited for cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy, administering the most effective therapy that the patient can tolerate is likely to produce positive outcomes.